Synapse - GDMT, Medicine

Results (1901)

Compositional and architectural characterization of high-grade serous ovarian carcinomas using single cell technologies and multiplex microscopy

Meeting Abstract

Kim, S. H.; Holland, A.; Jimenez-Sanchez, A.; Bykov, Y.; Fromme, R. M.; Stylianou, A.; Walther, T.; Liu, C.; Leitao, M. M. Jr; Zivanovic, O.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Mutation detection in cell-free DNA using ultra-high depth sequencing in prospectively collected newly diagnosed endometrial cancer patients

Meeting Abstract

Ashley, C. W.; Brown, D.; Lakhman, Y.; Nincevic, J.; Stylianou, A.; Wu, M.; Selenica, P.; Patel, J. A.; Berger, M. F.; Leitao, M. M. Jr; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial

Meeting Abstract

Swisher, E. M.; Coleman, R. L.; Bookman, M. A.; Brady, M. F.; Fleming, G. F.; Friedlander, M.; Cunningham, M. J.; Tewari, K. S.; Edraki, B.; Moxley, K.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

MILO/ENGOT-ov11: Phase-3 study of binimetinib versus physician's choice chemotherapy in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum

Meeting Abstract

Grisham, R. N.
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer

Meeting Abstract

Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C.
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Circulating cell-free DNA in patients with newly diagnosed and recurrent cervical cancer

Meeting Abstract

Kim, S. H.; Wu, M.; Stylianou, A.; Ghafoor, S.; Lakhman, Y.; Park, K. J.; Leitao, M. M. Jr; Sonoda, Y.; Gardner, G. J.; Broach, V.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study

Meeting Abstract

Bae-Jump, V. L.; Sill, M.; Gehrig, P. A.; Moxley, K.; Hagemann, A. R.; Waggoner, S. E.; O'Cearbhaill, R. E.; McDonald, M.; DiSilvestro, P. A.; Sperduto, P.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Tolerability and adverse events experienced by women with ovarian cancer treated with intravenous or intraperitoneal chemotherapy plus veliparib and bevacizumab based on BRCA status

Meeting Abstract

Gillen, J.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Outcomes based on treatment regimen in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum-based chemotherapy in combination with veliparib and bevacizumab

Meeting Abstract

Washington, C. R.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer

Meeting Abstract

Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save